Cover Your Bases Campaign Kicks Off Oral Health Month with ARESTIN (minocycline HCI) Patient Ambassador Alex Rodriguez LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its oral health… Read More
VANCOUVER, BC — (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that… Read More
Healthy subjects have been dosed with Filament’s botanical psilocybin and psilocin drug candidates VANCOUVER, BC — Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament”or the “Company”), a clinical‐stage natural psychedelic drug development… Read More
Two global Phase 3 trials in adults with CLL demonstrated superior efficacy for BRUKINSA in first line and relapsed/refractory settings TORONTO, ON — /CNW/ — BeiGene, Ltd. (NASDAQ: BGNE) (HKEX: 06160) (SSE: 688235),… Read More
MISSISSAUGA, ON — Hoffmann-La Roche Limited (Roche Canada) today announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for VABYSMO® (faricimab injection), indicated for the treatment… Read More
